Picture of Botanix Pharmaceuticals logo

BOT Botanix Pharmaceuticals Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Annual cashflow statement for Botanix Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital7.746.992.793.730.076
Other Operating Cash Flow
Cash from Operating Activities-17.4-2.97-11.2-12.1-8.13
Capital Expenditures-0.09-0.008-2.92-7.05-18
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.0610
Purchase of Investments
Cash from Investing Activities-0.151-0.008-2.92-7.05-18
Financing Cash Flow Items-3.160-1.44-5.76
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities37.3-0.126-0.1522295.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash19.9-3.09-14.32.9669.1